Living Evidence - To Establish a National COVID-19 Clinical Evidence Taskforce

  • Elliott, Julian (Primary Chief Investigator (PCI))
  • Green, Sally (Chief Investigator (CI))
  • Zoungas, Sophia (Chief Investigator (CI))
  • Buchbinder, Rachelle (Chief Investigator (CI))
  • Craig, Jonathan C. (Chief Investigator (CI))
  • McGowan, Sharon (Chief Investigator (CI))
  • Tendal, Britta (Chief Investigator (CI))
  • Tate, Rhiannon (Chief Investigator (CI))
  • Turner, Tari (Chief Investigator (CI))
  • McDonald, Steve (Chief Investigator (CI))
  • Murano, Melissa (Project Manager)

Project: Research

Project Details

Project Description

The Ian Potter Foundation has invited the Australian Living Evidence Consortium to apply for a Major Grant of $2.5million over 5 years as part of a multi-partner funding strategy to deliver Phase Two of the world-leading Living Evidence initiative. This follows the development of a business case for investment at the request of the Victorian Department of Health and Human Services. The Ian Potter Foundation will consider this application in the context of ongoing negotiations with Commonwealth and State governments and other philanthropic organisations to raise a total of $25million in funding commitments to deliver the program from 2020/21 to 2024/25.
StatusActive
Effective start/end date25/03/2031/12/20

Keywords

  • Evidence Synthesis
  • Clinical Practice Guidelines
  • Living Evidence
  • Living Guidelines
  • systematic reviews
  • Automation
  • Machine Learning